Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sorrento Therpt (SRNE)

Sorrento Therpt (SRNE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,471,812
  • Shares Outstanding, K 287,420
  • Annual Sales, $ 39,990 K
  • Annual Income, $ -298,460 K
  • 60-Month Beta 2.37
  • Price/Sales 62.32
  • Price/Cash Flow N/A
  • Price/Book 10.73
Trade SRNE with:

Options Overview

Details
  • Implied Volatility 86.92%
  • Historical Volatility 60.19%
  • IV Percentile 3%
  • IV Rank 3.31%
  • IV High 242.39% on 01/27/21
  • IV Low 81.60% on 06/01/21
  • Put/Call Vol Ratio 0.07
  • Today's Volume 27,474
  • Volume Avg (30-Day) 23,263
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 280,679
  • Open Int (30-Day) 347,234

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.22
  • Number of Estimates 4
  • High Estimate 1.44
  • Low Estimate -0.24
  • Prior Year -0.22
  • Growth Rate Est. (year over year) +200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.93 +25.40%
on 05/26/21
10.27 -15.38%
on 06/14/21
+1.48 (+20.53%)
since 05/21/21
3-Month
6.14 +41.53%
on 05/13/21
10.27 -15.38%
on 06/14/21
-0.87 (-9.10%)
since 03/19/21
52-Week
4.76 +82.56%
on 06/22/20
19.39 -55.18%
on 08/10/20
+3.89 (+81.04%)
since 06/19/20

Most Recent Stories

More News
AtriCure Names Two New Members to the Board of Directors

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that Deborah H. Telman and Maggie Yuen have been...

ATRC : 76.53 (+2.67%)
OGN : 29.41 (-1.90%)
MRK : 76.75 (+0.18%)
SRNE : 8.69 (+1.05%)
JCI : 66.33 (+2.93%)
ABT : 111.44 (+1.01%)
BA : 245.28 (+3.34%)
PEN : 273.69 (+2.29%)
TMO : 483.56 (+0.23%)
BSX : 43.60 (+1.35%)
Thinking about buying stock in Mereo BioPharma, Lipocine, Lordstown Motors, Sorrento Therapeutics, or Axcella Health?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MREO, LPCN, RIDE, SRNE, and AXLA.

AXLA : 4.32 (+0.47%)
MREO : 3.20 (-4.48%)
RIDE : 10.07 (-5.45%)
LPCN : 1.3400 (-1.47%)
SRNE : 8.69 (+1.05%)
Why The Relaxation In Lockdowns Is Expected To Drive The Demand For COVID-19 Diagnostics Market

, /PRNewswire/ -- As the world has adapted to the initial phase of the global pandemic, and vaccines are being manufactured to supply the ever growing demand, tests for the virus are in great demand themselves!...

GWHP : 0.4700 (+15.88%)
NVAX : 180.99 (+3.77%)
SRNE : 8.69 (+1.05%)
MRNA : 208.24 (+4.54%)
PFE : 39.42 (+1.57%)
Thinking about buying stock in AC Immune, Ashford Hospitality Trust, Sorrento Therapeutics, Jaguar Health, or Exela Technologies?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACIU, AHT, SRNE, JAGX, and XELA.

ACIU : 8.11 (+2.27%)
JAGX : 1.7000 (+4.94%)
SRNE : 8.69 (+1.05%)
XELA : 1.3500 (+5.47%)
AHT : 5.09 (unch)
Novel Anti-Cancer Drugs Permeate the Marketplace

, /PRNewswire/ -- The cancer therapeutics market is one of the largest segments of the biotechnology industry. According to the National Cancer Institute, roughly 1.8 million people were diagnosed with...

SBFM : 0.1620 (+23.95%)
VSTM : 4.85 (+1.68%)
TRIL : 10.17 (+3.67%)
IMGN : 6.55 (-2.09%)
SRNE : 8.69 (+1.05%)
Moving Average Crossover Alert: Sorrento Therapeutics (SRNE)

Sorrento Therapeutics (SRNE) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

SRNE : 8.69 (+1.05%)
The Importance of Alternative Healthcare Options Grows in the Midst of the Pandemic

, /PRNewswire/ -- While the pandemic continues to be a heavy burden on the economy and the healthcare system, there are several developments that point to positive signs in the fight against the virus....

TOMDF : 0.0418 (+11.47%)
PFE : 39.42 (+1.57%)
DVAX : 9.26 (+3.70%)
SRNE : 8.69 (+1.05%)
New Strong Sell Stocks for March 31st

AROW, BGS, KEX, SRNE, and TOSYY have been added to the Zacks Rank #5 (Strong Sell) List on March 31, 2021

KEX : 63.58 (+3.06%)
TOSYY : 21.8800 (+1.53%)
BGS : 33.13 (unch)
AROW : 36.18 (unch)
SRNE : 8.69 (+1.05%)
A US Government Interagency Group Defines Three Classes Of SARS-Cov-2 Variants

, /PRNewswire/ -- While the world has reason to become optimistic about seeing a light at the end of the tunnel, due to the development of vaccines to fight and rein in the current global pandemic, more...

AZN : 58.31 (-0.10%)
BIOV.CN : 0.255 (+10.87%)
LMNGF : 0.2405 (-7.00%)
SRNE : 8.69 (+1.05%)
NVAX : 180.99 (+3.77%)
MRNA : 208.24 (+4.54%)
Thinking about trading options or stock in Netflix, Novavax, Sorrento Therapeutics, Pfizer, or Johnson & Johnson?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NFLX, NVAX, SRNE, PFE, and JNJ.

NFLX : 497.00 (-0.75%)
NVAX : 180.99 (+3.77%)
SRNE : 8.69 (+1.05%)
JNJ : 163.84 (+1.15%)
PFE : 39.42 (+1.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and...

See More

Key Turning Points

3rd Resistance Point 9.15
2nd Resistance Point 8.94
1st Resistance Point 8.81
Last Price 8.69
1st Support Level 8.47
2nd Support Level 8.26
3rd Support Level 8.13

See More

52-Week High 19.39
Fibonacci 61.8% 13.80
Fibonacci 50% 12.07
Fibonacci 38.2% 10.35
Last Price 8.69
52-Week Low 4.76

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar